Drug Company

Apr 28, 2017 at 14:55 | Source:
Notice is hereby given that the meeting of the Board of Directors of the Company will be held on Monday, 08th May, 2017.
Apr 26, 2017 at 20:50 | Source:
National Pharmaceutical Pricing Authority said on Wednesday said that the companies cannot pull their stents from the market abruptly after the duo had cited commercial viability concerns in their withdrawal applications.
Apr 25, 2017 at 14:36 | Source: PTI
The company has received "final approval from the United States Food and Drug Administration (USFDA) to market olmesartan medoxomil tablets in the strengths of 5 mg, 20 mg and 40 mg", Cadila Healthcare said in a filing to BSE. The drug is an anti-hypertensive and will be produced at the group's formulations manufacturing facility in Ahmedabad, it added.
Apr 25, 2017 at 11:30 | Source: PTI
"The company has received abbreviated new drug application (ANDA) final approval for olmesartan medoxomil tablets, 5 mg, 20 mg, and 40 mg and olmesartan medoxomil with hydrochlorothiazide tablets 20/12.5mg, 40/12.5mg and 40/25mg," Alembic Pharmaceuticals said in a BSE filing today.
Apr 25, 2017 at 11:15 | Source: PTI
In a BSE filing, the company said it has received abbreviated new drug application (ANDA) final approval for olmesartan medoxomil tablets - 5 mg, 20 mg, and 40 mg.
Apr 25, 2017 at 11:05 | Source:
This is second approval that company has received from the USFDA during the current financial year.
Apr 22, 2017 at 15:19 | Source: PTI
Drug firm Divis Laboratories today said the US health regulator has issued a warning letter to the company for its Vishakhapatnam facility.
Apr 22, 2017 at 13:26 | Source: CNBC-TV18
In a setback for Divi's Lab, the US FDA has issued a warning letter for the company's unit-II at Visakhapatnam. Ekta Batra has more details.
Apr 21, 2017 at 19:53 | Source: PTI
Drug firm Dr Reddy's today said it has launched generic Progesterone capsules used in treatment of menstrual irregularities and protection of the lining of uterus in the US market.
Apr 19, 2017 at 15:15 | Source: PTI
The United States Food and Drug Administration (USFDA) had conducted an inspection at the company's Unit III, a formulations manufacturing facility at Bachupally, Hyderabad from April 10, 2017 to April 18, 2017, Aurobindo Pharma said in a filing to BSE.
Messages on Drug Company »


New Member


Marksans Pharma  

These Drug companies need Yogiji for their quality control issues. This kind of problem is rampant in all the pharma space. They are just burning the prudent investor`s wealth.

2.39 PM Apr 25th


Silver Member


Coral Labs  

As Govt is emphasizing more on generic drugs, companies like Corol Labs are going to benefit most. Corol is leader in manufacturing generic drugs.

12.36 PM Apr 20th


New Member


Novartis India  

Undervalued is an understatement. Sitting on cash close to its Mcap and this is drug company that`s heavily into research and dev. Has a long way to run, but and forget :)

3.33 PM Mar 24th


Platinum Member


Aurobindo Pharm  

US court has ruled in favour of Indian generic drug company Aurobindo Pharma in a patent infringement suit filed by New Jersey-based Reckitt Benckiser, on a generic version of the latter`s extended release cough and cold drug, Mucinex DM. In 2014, Aurobindo had filed an Abbreviated New Drug

7.56 PM Mar 14th


Platinum Member


Aurobindo Pharm  

CONCORD — Over steak dinners and at trade shows and a girls night out, drug company executives and employees rigged the prices for generic drugs, boosting their costs on average by 448 percent, according to a lawsuit filed by Connecticut Attorney General George Jepsen in U.S. District Court

12.54 PM Mar 2nd


New Member


Natco Pharma  

conusmers the role plaed by Indian pharma than begging them to ease the coercive measures done by FDA on Indian drug companies.

6.11 PM Feb 10th

Wire News

Platinum Member


News Now  

Stocks of pharmaceutical companies came under heavy selling pressure today following US President Donald Trump's strong remarks on high prices of medicines and new procedure for bidding on drugs indicating a difficult environment in the US, the largest market for Indian generic drug companies.

9.38 PM Jan 31st


New Member


Sun Pharma  

Indian drug company to take skin route for branded us speciality play & Sunpharma is acquiring Novartis skin odozmo brand, increasing business in US in skin dermatology segment this will increase annual sale by 500 crore good for long term buy & hold for long term buy on dips

1.12 PM Dec 29th 2016


New Member


Divis Labs  

FDA people are a bunch of crooks. You should see the wrongdoing they do in their own country. For example - for new drug approval now they don`t even require testing versus placebo. American drug companies are highly unethical (do a google search, you will find out how the FDA has sold its soul

5.31 PM Dec 26th 2016


New Member


Tyche Ind  

hope on performance of this drug company...let us wait and see...!!!

8.24 PM Dec 15th 2016

News across the web »
Mar 17, 2017 at 02:00 | Source: FirstPost
Follow us on
Available On